Cadila Pharmaceuticals Ltd Vs DCIT (ITAT Ahmedabad)
Assessee got relief on corporate guarantee, R&D and registration claims while medical freebies and late welfare dues disallowed
Conclusion: Tribunal partly allowed the assessee’s appeals by granting relief on transfer pricing, scientific research deduction, product registration expenses, section 14A/MAT adjustment, and forex hedging losses, while upholding the disallowance of expenditure on freebies to doctors and delayed employees’ welfare contributions. The issue relating to deduction of bonus under section 43B was remanded to the Assessing Officer for verification of actual payment within the prescribed statutory period.
Held: Assessee-parent company had extended a corporate guarantee to a bank for loans availed by its overseas Associated Enterprise (AE) without incurring any cost, outflow, or economic sacrifice. The pharmaceutical assessee advanced interest-free funds to group entities while holding interest-bearing borrowings. AO alleged a diversion of funds, but the CIT(A) found commercial expediency and business nexus. Assessee claimed weighted deductions under section 35(2AB) for its approved in-house R&D facility. AO limited it to the amount in Form 3CL by DSIR. The assessee also raised an additional claim for deductions on the gross expenditure without reducing contract research receipts. The company incurred expenses to obtain mandatory statutory regulatory approvals to register and export its pharmaceutical products overseas, which the AO treated as capital expenditure. Assessee earned a minor exempt income ($\approx$ Rs. 0.05 lakhs). AO mechanically applied Rule 8D to disallow a higher amount under section 14A and subsequently added the same to the Book Profit computation under section 115JB for MAT. Assessee incurred losses on derivative/forward contracts entered into with banks to hedge against foreign exchange fluctuations on its regular import-export exposure. The company spent Rs. 4.92 crores on gifts, hospitality, sponsorships, and promotional incentives for medical practitioners. Assessee deposited employees’ contributions to the Gujarat Labour Welfare Fund and Modi Benevolent Fund after the specific welfare enactments’ due dates, but before the tax return filing deadline under section 139(1). Assessee claimed a deduction for bonus liabilities under section 43B, which was admitted by CIT(A) but required factual verification of actual payment. It was held that regarding Corporate Guarantee, a cost-free corporate guarantee without economic sacrifice did not constitute an “international transaction” under section 92B; no arm’s length commission could be imputed. Regarding Interest Disallowance, deletion of the disallowance under section 36(1)(iii) upheld because commercial expediency was proved and AO failed to establish a direct nexus between borrowed funds and interest-free advances. As regarding Scientific Research, for AY 2013-14, weighted deductions under section 35(2AB) could not be restricted to Form 3CL amounts as subsequent restrictive amendments were prospective. The additional claim on gross R&D expenditure was also allowed. Regarding Product Registration, registration expenses were revenue in nature as they did not create a transferable capital asset, but merely enable day-to-day export operations within statutory frameworks. Regarding exempt Income & MAT, disallowance under section 14A could not exceed the actual exempt income earned. Consequently, mechanical additions to MAT book profits under section 115JB were impermissible and would cause double disallowance. Regarding Forex Fluctuation, hedging losses arising from genuine derivative contracts linked to regular export-import operations were allowable business losses and could not be treated as speculative under section 43(5). Regarding freebies to Doctors, giving freebies or incentives to medical practitioners was prohibited by the Medical Council Regulations; hence, it was inadmissible under Explanation 1 to section 37(1). Regarding welfare contributions, employee welfare contributions must be deposited within the due dates prescribed under the respective welfare laws to qualify for deduction under section 36(1)(va); payments made late but before the section 139(1) deadline were not salvageable. Regarding Bonus Deductions, the issue was restored to the AO to verify documentary evidence confirming actual payment of the bonus within the prescribed statutory timelines under section 43B.
